95 related articles for article (PubMed ID: 214498)
1. Mechanisms of action of "lymphocyte-activating factor" (LAF). III. Evidence that LAF acts on stimulated lymphocytes by raising cyclic GMP in G1.
Katz SP; Kierszenbaum F; Waksman BH
J Immunol; 1978 Dec; 121(6):2386-91. PubMed ID: 214498
[No Abstract] [Full Text] [Related]
2. Mechanisms of action of 'lymphocyte activating factor' (LAF) I. Association of lymphocyte activating factor action with early DNA synthesis in PHA-stimulated lymphocytes.
Kiertdzenbaum F; Waksman BH
Immunology; 1977 Nov; 33(5):663-9. PubMed ID: 590994
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of action of "lymphocyte activating factor" (LAF)--II. LAF effect is resistant to elevation of cellular cyclic AMP.
Kierszenbaum F; Waksman BH
Immunochemistry; 1978 Nov; 15(10-11):807-11. PubMed ID: 218885
[No Abstract] [Full Text] [Related]
4. Regulatory substances produced by lymphocytes. VIII. Cell cycle specificity of inhibitor of DNA synthesis (IDS) action in lymphocytes.
Wagshal AB; Waksman BH
J Immunol; 1978 Sep; 121(3):966-72. PubMed ID: 211168
[No Abstract] [Full Text] [Related]
5. Concanavalin A and the initiation of thymic lymphoblast DNA synthesis and proliferation by a calcium-dependent increase in cyclic GMP level.
Whitfield JF; MacManus JP; Boynton AL; Gillan DJ; Isaacs RJ
J Cell Physiol; 1974 Dec; 84(3):445-58. PubMed ID: 4373488
[No Abstract] [Full Text] [Related]
6. Two distinct lumphocyte-stimulating soluble factors (LAF) released from murine peritoneal cells. I. The cellular source and the effect of cGMP on their release.
Diamantstein T; Ulmer A
Immunology; 1976 May; 30(5):741-7. PubMed ID: 179941
[TBL] [Abstract][Full Text] [Related]
7. Evidence for cyclic GMP and calcium mediation of lymphocyte activation by mitogens.
Coffey RG; Hadden EM; Hadden JW
J Immunol; 1977 Oct; 119(4):1387-94. PubMed ID: 197170
[No Abstract] [Full Text] [Related]
8. [Regulation of the cell cycle of B-lymphocytes in mice by substances elevating the levels of intracellular cAMP and cGMP].
Ado AD; Dontsov VI; Gol'dshteĭn MM
Biull Eksp Biol Med; 1985 Apr; 99(4):455-8. PubMed ID: 2985157
[TBL] [Abstract][Full Text] [Related]
9. Endogenous pyrogens made by rabbit peritoneal exudate cells are identical with lymphocyte-activating factors made by rabbit alveolar macrophages.
Murphy PA; Simon PL; Willoughby WF
J Immunol; 1980 May; 124(5):2498-501. PubMed ID: 6965973
[TBL] [Abstract][Full Text] [Related]
10. Nonspecific "lymphocyte activating" factors produced by macrophages.
Diamantstein T; Oppenheim JJ; Unanue ER; Wood DD; Handschumacher RE; Rosenstreich DL; Waksman BH
Clin Immunol Immunopathol; 1979 Oct; 14(2):264-7. PubMed ID: 226303
[No Abstract] [Full Text] [Related]
11. Characterization of lymphocyte-activating factor (LAF) produced by a macrophage cell line, P388D1. II. Biochemical characterization of LAF induced by activated T cells and LPS.
Mizel SB; Oppenheim JJ; Rosentreich DL
J Immunol; 1978 May; 120(5):1504-8. PubMed ID: 307016
[TBL] [Abstract][Full Text] [Related]
12. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
Marcoz P; Prigent AF; Lagarde M; Nemoz G
Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
[TBL] [Abstract][Full Text] [Related]
13. Cyclic nucleotides and calcium in human lymphocytes induced to divide.
Rochette-Egly C; Kempf J
J Physiol (Paris); 1981 Sep; 77(6-7):721-5. PubMed ID: 6270320
[TBL] [Abstract][Full Text] [Related]
14. Cyclic AMP and the immune response;
Parker CW; Sullivan TJ; Wedner HJ
Adv Cyclic Nucleotide Res; 1974; 4(0):1-79. PubMed ID: 4368552
[No Abstract] [Full Text] [Related]
15. Neurotransmitters, hormones, and cyclic nucleotides in lymphocyte regulation.
Coffey RG; Hadden JW
Fed Proc; 1985 Jan; 44(1 Pt 1):112-7. PubMed ID: 2857137
[TBL] [Abstract][Full Text] [Related]
16. Cyclic AMP and calcium as intracycle regulators in the control of cell proliferation.
MacManus JP; Boynton AL; Whitfield JF
Adv Cyclic Nucleotide Res; 1978; 9():485-91. PubMed ID: 208391
[No Abstract] [Full Text] [Related]
17. [The cellular immune system. Possible adverse effects of drugs].
Bruserud O
Tidsskr Nor Laegeforen; 1986 Aug; 106(24):1939-40, 1951. PubMed ID: 3022416
[No Abstract] [Full Text] [Related]
18. Mechanisms by which oxidative injury inhibits the proliferative response of human lymphocytes to PHA. Effect of the thiol compound 2-mercaptoethanol.
Gougerot-Pocidalo MA; Fay M; Roche Y; Chollet-Martin S
Immunology; 1988 Jun; 64(2):281-8. PubMed ID: 3391643
[TBL] [Abstract][Full Text] [Related]
19. Production of human leukocyte migration inhibitory factor (LIF) by lymphocytes stimulated with phytohemagglutinin. II. Effects of cyclic nucleotides.
Bendtzen K; Mahoney R; Rocklin RE
Clin Immunol Immunopathol; 1981 Feb; 18(2):221-9. PubMed ID: 6258834
[No Abstract] [Full Text] [Related]
20. [Cyclic nucleotide levels in activated human T lymphocytes].
Komissarenko SV
Ukr Biokhim Zh (1978); 1988; 60(3):30-4. PubMed ID: 2842905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
